Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

617 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cladribine and ocrelizumab induce differential miRNA profiles in peripheral blood mononucleated cells from relapsing-remitting multiple sclerosis patients.
Arisi I, Malimpensa L, Manzini V, Brandi R, Gosetti di Sturmeck T, D'Amelio C, Crisafulli S, Ferrazzano G, Belvisi D, Malerba F, Florio R, Pascale E, Soreq H, Salvetti M, Cattaneo A, D'Onofrio M, Conte A. Arisi I, et al. Among authors: salvetti m. Front Immunol. 2023 Dec 13;14:1234869. doi: 10.3389/fimmu.2023.1234869. eCollection 2023. Front Immunol. 2023. PMID: 38152407 Free PMC article.
A controlled study of potential risk factors preceding exacerbation in multiple sclerosis.
Gasperini C, Grasso MG, Fiorelli M, Millefiorini E, Morino S, Anzini A, Colleluori A, Salvetti M, Buttinelli C, Pozzilli C. Gasperini C, et al. Among authors: salvetti m. J Neurol Neurosurg Psychiatry. 1995 Sep;59(3):303-5. doi: 10.1136/jnnp.59.3.303. J Neurol Neurosurg Psychiatry. 1995. PMID: 7673961 Free PMC article. Clinical Trial.
Multiple sclerosis: pharmacogenomics and personalised drug treatment.
Annibali V, Ristori G, Cannoni S, Romano S, Visconti A, Ghazaryan A, Figà Talamanca L, Salvetti M, Mechelli R. Annibali V, et al. Among authors: salvetti m. Neurol Sci. 2006 Sep;27 Suppl 5:S347-9. doi: 10.1007/s10072-006-0691-y. Neurol Sci. 2006. PMID: 16998717 Review.
TET2 gene expression and 5-hydroxymethylcytosine level in multiple sclerosis peripheral blood cells.
Calabrese R, Valentini E, Ciccarone F, Guastafierro T, Bacalini MG, Ricigliano VA, Zampieri M, Annibali V, Mechelli R, Franceschi C, Salvetti M, Caiafa P. Calabrese R, et al. Among authors: salvetti m. Biochim Biophys Acta. 2014 Jul;1842(7):1130-6. doi: 10.1016/j.bbadis.2014.04.010. Epub 2014 Apr 13. Biochim Biophys Acta. 2014. PMID: 24735979 Free article.
IFN-β and multiple sclerosis: from etiology to therapy and back.
Annibali V, Mechelli R, Romano S, Buscarinu MC, Fornasiero A, Umeton R, Ricigliano VA, Orzi F, Coccia EM, Salvetti M, Ristori G. Annibali V, et al. Among authors: salvetti m. Cytokine Growth Factor Rev. 2015 Apr;26(2):221-8. doi: 10.1016/j.cytogfr.2014.10.010. Epub 2014 Oct 31. Cytokine Growth Factor Rev. 2015. PMID: 25466632 Review.
Intestinal Permeability in Relapsing-Remitting Multiple Sclerosis.
Buscarinu MC, Romano S, Mechelli R, Pizzolato Umeton R, Ferraldeschi M, Fornasiero A, Reniè R, Cerasoli B, Morena E, Romano C, Loizzo ND, Umeton R, Salvetti M, Ristori G. Buscarinu MC, et al. Among authors: salvetti m. Neurotherapeutics. 2018 Jan;15(1):68-74. doi: 10.1007/s13311-017-0582-3. Neurotherapeutics. 2018. PMID: 29119385 Free PMC article. Review.
617 results